Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 11.57% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.39
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 19 Cr (Micro Cap)
100.00
37
0.00%
-0.67
5.25%
1.76
Total Returns (Price + Dividend) 
Latest dividend: 0.1800 per share ex-dividend date: Oct-29-2009
Risk Adjusted Returns v/s 
Returns Beta
News

Jayshree Chemicals Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
Jayshree Chemicals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 28 Sep 2026, reflecting a deteriorating technical outlook and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s micro-cap status, negative EBITDA, and underwhelming long-term returns have contributed to a cautious stance among investors.
Read More
Jayshree Chemicals Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Concerns
Jayshree Chemicals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators signalling a mildly bullish trend. Despite this positive technical momentum, the company continues to face significant fundamental headwinds, including operating losses and weak long-term financial strength, which temper the overall outlook for investors.
Read More Announcements 
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026
12-Nov-2026 | Source : BSEWe send herewith the Unaudited Financial Results of the Company for the quarter and half year ended on 30th September 2026 which were approved by the Board of Directors at their meeting held on 12th November 2026
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026
12-Nov-2026 | Source : BSEWe send herewith the Unaudited Financial Results of the Company for the quarter and half year ended on 30th September 2026 which were approved by the Board of Directors at their meeting held on 12th November 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2026
12-Nov-2026 | Source : BSEPursuant to Regulation 33 of SEBI (LODR) Regulations 2015 we send herewith the Unaudited Financial Results of the Company for the quarter and half year ended on 30th September 2026 which were approved by the Board of Directors at their Meeting held today i.e. 12th November 2026 as recommended by the Audit Committee.
Corporate Actions 
No Upcoming Board Meetings
Jayshree Chemicals Ltd has declared 10% dividend, ex-date: 29 Oct 09
No Splits history available
No Bonus history available
Jayshree Chemicals Ltd has announced 9:2 rights issue, ex-date: 17 Feb 10
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 1 Schemes (0.0%)
Held by 0 FIIs
Veer Enterprises Ltd (10.71%)
Shaunak Jagdish Shah (4.47%)
49.61%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 23.17% vs 7.19% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 100.00% vs -63.16% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 22.12% vs 21.30% in Sep 2024
Growth in half year ended Sep 2025 is 300.00% vs -95.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 22.94% vs 27.57% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 220.00% vs -147.62% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 29.15% vs 26.29% in Mar 2025
YoY Growth in year ended Mar 2026 is 214.81% vs 92.31% in Mar 2025